Decibel Therapeutics and Invitae have partnered to offer sponsored, no-charge genetic testing for individuals diagnosed with auditory neuropathy.
The Amplify™ program removes barriers to genetic diagnosis for patients born with auditory neuropathy. There are several known genetic causes of auditory neuropathy. Through the program, patients diagnosed with auditory neuropathy have access to genetic testing to help bring them one step closer to diagnosis and appropriate clinical management. Additionally, the prevalence information gained from this program will help with novel therapeutic development.